
IMPROVE THE STANDARD OF CARE IN THE USA
Prevent avoidable deaths!
Prevent avoidable deaths!
Testing for DPD/DPYD deficiency prior to the start of chemotherapy with 5-FU (Fluorouracil) or Capecitabine (Xeloda) can reduce suffering and save lives.
Testing for DPD/DPYD deficiency prior to the start of chemotherapy with 5-FU or Capecitabine (Xeloda) can reduce suffering and save lives.
Ask your oncologist to test for DPD deficiency BEFORE starting chemotherapy with 5-FU/capecitabine. This will help determine if the treatment is one you can tolerate.
Oncologists may dismiss the need to test. You can point out that pre-treatment testing is the standard of care in Europe, many leading US cancer centers are testing, and now the FDA and NCCN both suggest oncologists discuss the benefits of pre-treatment testing with patients.
What you need to know:
Our Mission
To improve the standard of care in the United States for cancer patients undergoing fluoropyrimidine chemotherapy (5-FU and/or Capecitabine), through advocacy, education and research.